Literature DB >> 17637780

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions.

Juliane Winkelmann1, Barbara Schormair, Peter Lichtner, Stephan Ripke, Lan Xiong, Shapour Jalilzadeh, Stephany Fulda, Benno Pütz, Gertrud Eckstein, Stephanie Hauk, Claudia Trenkwalder, Alexander Zimprich, Karin Stiasny-Kolster, Wolfgang Oertel, Cornelius G Bachmann, Walter Paulus, Ines Peglau, Ilonka Eisensehr, Jacques Montplaisir, Gustavo Turecki, Guy Rouleau, Christian Gieger, Thomas Illig, H-Erich Wichmann, Florian Holsboer, Bertram Müller-Myhsok, Thomas Meitinger.   

Abstract

Restless legs syndrome (RLS) is a frequent neurological disorder characterized by an imperative urge to move the legs during night, unpleasant sensation in the lower limbs, disturbed sleep and increased cardiovascular morbidity. In a genome-wide association study we found highly significant associations between RLS and intronic variants in the homeobox gene MEIS1, the BTBD9 gene encoding a BTB(POZ) domain as well as variants in a third locus containing the genes encoding mitogen-activated protein kinase MAP2K5 and the transcription factor LBXCOR1 on chromosomes 2p, 6p and 15q, respectively. Two independent replications confirmed these association signals. Each genetic variant was associated with a more than 50% increase in risk for RLS, with the combined allelic variants conferring more than half of the risk. MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637780     DOI: 10.1038/ng2099

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  202 in total

1.  Genetic underpinnings of obstructive sleep apnea: are we making progress?

Authors:  Patrick Sleiman; Hakon Hakonarson
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  RLS in middle aged women and attention deficit/hyperactivity disorder in their offspring.

Authors:  Xiang Gao; Kristen Lyall; Natalia Palacios; Arthur S Walters; Alberto Ascherio
Journal:  Sleep Med       Date:  2011-01       Impact factor: 3.492

3.  Restless legs syndrome and Parkinson's disease in men.

Authors:  Xiang Gao; Michael A Schwarzschild; Eilis J O'Reilly; Hao Wang; Alberto Ascherio
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 4.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 5.  Genetic analysis of sleep.

Authors:  Amanda Crocker; Amita Sehgal
Journal:  Genes Dev       Date:  2010-06-15       Impact factor: 11.361

Review 6.  Update in restless legs syndrome.

Authors:  Rachel E Salas; Charlene E Gamaldo; Richard P Allen
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

Review 7.  Approaches to unravel the genetics of sleep.

Authors:  Mikhil N Bamne; Hader Mansour; Timothy H Monk; Daniel J Buysse; Vishwajit L Nimgaonkar
Journal:  Sleep Med Rev       Date:  2010-03-17       Impact factor: 11.609

8.  Evaluating variations of genotype calling: a potential source of spurious associations in genome-wide association studies.

Authors:  Huixiao Hong; Zhenqiang Su; Weigong Ge; Leming Shi; Roger Perkins; Hong Fang; Donna Mendrick; Weida Tong
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

9.  The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders.

Authors:  Kevin P Jensen; Henry R Kranzler; Murray B Stein; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-16       Impact factor: 3.568

Review 10.  Kinase mutations in human disease: interpreting genotype-phenotype relationships.

Authors:  Piya Lahiry; Ali Torkamani; Nicholas J Schork; Robert A Hegele
Journal:  Nat Rev Genet       Date:  2010-01       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.